PT  - JOURNAL ARTICLE
AU  - Bentley, P. M.
TI  - Error Rates in SARS-CoV-2 Testing Examined with Bayesian Inference *
AID  - 10.1101/2020.12.17.20248402
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.12.17.20248402
4099  - http://medrxiv.org/content/early/2020/12/19/2020.12.17.20248402.short
4100  - http://medrxiv.org/content/early/2020/12/19/2020.12.17.20248402.full
AB  - A literature review on SARS-CoV-2 reverse-transcription polymerase chain reaction (RT-PCR) is used to construct a clinical test confusion matrix, including false positives and false negatives. A simple correction of bulk test data results is demonstrated, then the required sensitivity and specificity are explored for the societal needs. It is indicated that many of the people with mild symptoms and positive test results are unlikely to be infected with SARS-CoV-2 in some regions. It is also concluded that current and foreseen alternative tests cannot be used to “clear” patients, students or workers as being non-infected. Recommendations are given that regional authorities must establish a programme to monitor operational test characteristics before launching large scale testing; and that large scale testing for tracing infection networks in some regions is not viable, but may be possible in a focused way that does not exceed the working capacity of the competent expert laboratories.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:None required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used is all from peer-reviewed, referenced sources as stated in the article itself.